Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008–2016

Autor:	Penina Haber, Muhammad Amin, Carmen Ng, Eric Weintraub, Michael M. McNeil
Jazyk:	angličtina
Rok vydání:	2018
Předmět:	adverse event passive surveillance rotavirus rotavirus vaccine vaccine safety vaers Immunologic diseases. Allergy RC581-607 Therapeutics. Pharmacology RM1-950
Zdroj:	Human Vaccines & Immunotherapeutics, Vol 14, Iss 11, Pp 2755-2759 (2018)
Druh dokumentu:	article
ISSN:	2164-5515 2164-554X 21645515
DOI:	10.1080/21645515.2018.1491509
Popis:	A 2018 manufacturer post-licensure safety study identified a possible association between Rotarix (RV1) rotavirus vaccine and lower respiratory tract infections (LRTI) in infants within 0–6 days following receipt of RV1 dose 1. We reviewed reports to the Vaccine Adverse Event Reporting System (VAERS) of LRTI occurring 0–6 days and 0–29 days post vaccination following RotaTeq (RV5) or Rotarix (RV1) vaccinations in conjunction with either Prevnar (PCV7) or Prevnar 13 (PCV13), in infants aged 6 to 15 weeks. There was no significant difference in LRTI reports to VAERS in the 0–6 days and 0–29 days following receipt of either RV5 or RV1 given with either pneumococcal vaccine.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/360e882f06b1453583d2bb8b11109892 Zobrazit plný text záznamu View record in DOAJ